Apolipoproteins and carotid artery atherosclerosis in an elderly multiethnic population: The Northern Manhattan stroke study

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 317-325

  Jeng, Jiann Shing ^a   Sacco, Ralph L ^a   Kargman, Douglas E ^a   Boden Albala, Bernadette ^a   Paik, Myunghee C ^a   Jones, Jeffrey ^a   Berglund, Lars ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein; Atherosclerosis; Carotid arteries; Racial differences; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOLIPOPROTEIN; LIPID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COMMUNITY CARE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; ELDERLY CARE; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; STROKE; UNITED STATES; ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; BLOOD; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ECHOGRAPHY; ETHNIC GROUP; ETHNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APOLIPOPROTEINS; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; CEREBROVASCULAR ACCIDENT; ETHNIC GROUPS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 0036890342     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00246-0     Document Type: Article

References (30)

1. Burchfiel C.M., Laws A., Benfante R., Goldberg R.J., Hwang L.J., Chiu D., et al. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation. 92:1995;1430-1436.
2. Fine-Edelstein J.S., Wolf P.A., O'Leary D.H., Poehlman H., Belanger A.J., Kase C.S., et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology. 44:1994;1046-1050.
3. ARIC Investigators, Heiss G., Sharrett R., Barnes R., Chambless L.E., Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in population: associations with cardiovascular risk factors in the ARIC Study. Am. J. Epidemiol. 134:1991;250-256.
4. Kuller L., Borhani N., Furberg C., Gardin J., Manolio T., O'Leary D., et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am. J. Epidemiol. 139:1994;1164-1179.
5. Kuller L., Fisher L., McClelland R., Fried L., Cushman M., Jackson S., et al. Differences in prevalence of and risk factor for subclinical vascular disease among black and white participants in the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 18:1998;283-293.
6. Sutton-Tyrrell K., Alcorn H.G., Wolfson S.K., Kelsey S.F., Kuller L.H. Predictors of carotid stenosis in older adults with and without isolated systolic hypertension. Stroke. 24:1993;355-361.
7. Kronmal R.A., Cain K.C., Ye Z., Omenn G.S. Total serum cholesterol levels and mortality risk as a function of age: a report based on the Framingham data. Arch. Intern. Med. 153:1993;1065-1073.
8. Krumholz H.M., Seeman T.E., Merrill S.S., Mendes de Leon C.F., Vaccarino V., Silverman D.I., et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 272:1994;1335-1340.
9. Scandinavian Simvastatin Study Group, Miettinen T.A., Pyorala K., Olsson A.G., Musliner T.A., Cook T.J., Faergeman O., et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation. 96:1997;4211-4218.
10. Sacco R.L., Roberts J.K., Boden-Albala B., Gu Q., Lin I.F., Kargman D.E., et al. Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke. 28:1997;929-935.
11. Lamarche B., Moorjani S., Lupien P.J., Cantin B., Bernard P.-M., et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study. Circulation. 94:1996;273-278.
12. Sharett A.R., Patsch W., Sorlie P.D., Heiss G., Bond M.G., Davis C.E. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 14:1994;1098-1104.
13. Sharett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 104:2001;1108-1113.
14. Wilson P.W., Anderson K.M., Harris T., Kannel W.B., Castelli W.P. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J. Gerontol. 49:1994;M252-M257.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 28S, 2486-97.
16. The Northern Manhattan Stroke Study Collabrators, Sacco R.L., Boden-Albala B., Gan R., Chen X., Kargman D.E., Shea S., et al. Stroke incidence among white, black, and Hispanic residents of an urban community. The Northern Manhattan Stroke Study. Am. J. Epidemiol. 147:1998;259-268.
17. Gentry E.M., Kalsbeek W.D., Hogelin G.C., Jones J.T., Gaines K.L., Forman M.R., et al. The Behavioral Risk Factor Surveys, II: design, methods and estimates from combined state data. Am. J. Prev. Med. 1:1985;9-14.
18. Sacco R.L., Gan R., Boden-Albala B., Lin I.F., Kargman D.E., Hauser W.A., et al. Leisure-time physical activity and ischemic stroke risk. The Northern Manhattan Stroke Study. Stroke. 29:1998;380-387.
19. Tuck C.H., Holleran S., Berglund L. Hormonal regulation of lipoprotein(a) levels: Effect of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 17:1997;1822-1829.
20. Hartman A., Mohr J.P., Thompson J.L., Ramos O., Mast H. Interrater reliability of plaque morphology classification in patients with severe carotid artery stenosis. Acta Neurol. Scand. 99:1999;61-64.
21. Sacco R.L., Kargman D.E., Zamanillo M.C. Race-ethnicity in stroke risk factors among hospitalized patients with cerebral infarction: The Northern Manhattan Stroke Study. Neurology. 45:1995;659-663.
22. D'Agostino R.B., Burke G., O'Leary D., Rewers M., Selby J., Savage P.J., et al. Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke. 27:1996;1744-1749.
23. Winkleby M.A., Kraemer H.C., Ahn D.K., Varady A.N. Ethnic and socioeconomic differences in cardiovascular disease risk factors. Findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA. 280:1988;356-362.
24. Liao Y., Cooper R.S., Cao G., Kaufman J.S., Long A.E., McGee D.L. Mortality from coronary heart disease and cardiovascular disease among adult US Hispanics: findings from the National Health Interview Survey (1986-1994). J. Am. Coll. Cardiol. 30:1997;1200-1205.
25. Lamarche B., Tchernof A., Mauriège P., Cantin B., Dagenais G.R., Lupien P.J., et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 279:1998;1955-1961.
26. Reardon M.F., Nestel P.J., Craig I.H., Harper R.W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 71:1985;881-888.
27. Rosseneu M., Fruchart J.C., Bard J.M., Nicaud V., Vinaimont N., Cambien F., et al. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. Circulation. 89:1994;1967-1973.
28. Willeit J., Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler. Thromb. 13:1993;661-668.
29. Sacco R.L., Benson R.T., Kargman D.E., Boden-Albala B., Tuck C., Lin I.-F., et al. The protective effects of high density lipoprotein cholesterol for ischemic stroke in the elderly: The Northern Manhattan Stroke Study. JAMA. 285:2001;2729-2735.
30. Stampfer M.J., Sacks F.M., Salvini S., Willett W.C., Hennekens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325:1991;373-381.